Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0CE7G
|
|||
| Drug Name |
Cyclohexyl-ethyl-substituted diaza and triaza-tricyclic compound 1
|
|||
| Synonyms |
PMID29473428-Compound-38
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
MERCK PATENT GMBH SHERER, Brian A
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H20F2N2O
|
|||
| Canonical SMILES |
C1CC(CCC1O)(CCC2C3=C(C=CC=C3F)C4=CN=CN24)F
|
|||
| InChI |
1S/C18H20F2N2O/c19-14-3-1-2-13-16-10-21-11-22(16)15(17(13)14)6-9-18(20)7-4-12(23)5-8-18/h1-3,10-12,15,23H,4-9H2
|
|||
| InChIKey |
AHMWQTITKYANIA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target Info | Antagonist | [1] |
| Target's Patent Info | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target's Patent Info | [1] | |
| BioCyc | Superpathway of tryptophan utilization | |||
| Tryptophan degradation | ||||
| L-kynurenine degradation | ||||
| Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde | ||||
| NAD de novo biosynthesis | ||||
| KEGG Pathway | Tryptophan metabolism | |||
| Metabolic pathways | ||||
| African trypanosomiasis | ||||
| NetPath Pathway | TSLP Signaling Pathway | |||
| IL5 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | ||||
| Pathwhiz Pathway | Tryptophan Metabolism | |||
| Reactome | Tryptophan catabolism | |||
| WikiPathways | Tryptophan metabolism | |||
| Metabolism of amino acids and derivatives | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A patent review of IDO1 inhibitors for cancer.Expert Opin Ther Pat. 2018 Apr;28(4):317-330. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.